Apyx Medical Corporation
APYX
$3.99
-$0.04-0.99%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.22% | 20.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.22% | 20.60% | |||
| Cost of Revenue | 6.76% | 13.94% | |||
| Gross Profit | 17.14% | 25.03% | |||
| SG&A Expenses | -5.72% | 11.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.71% | 11.75% | |||
| Operating Income | 67.68% | 15.63% | |||
| Income Before Tax | 49.12% | 10.53% | |||
| Income Tax Expenses | 59.18% | 0.00% | |||
| Earnings from Continuing Operations | 47.70% | 10.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 27.50% | -281.82% | |||
| Net Income | 47.49% | 8.96% | |||
| EBIT | 67.68% | 15.63% | |||
| EBITDA | 72.65% | 16.17% | |||
| EPS Basic | 47.52% | 8.93% | |||
| Normalized Basic EPS | 48.78% | 8.13% | |||
| EPS Diluted | 47.52% | 8.93% | |||
| Normalized Diluted EPS | 48.78% | 8.13% | |||
| Average Basic Shares Outstanding | 0.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||